Diosmetin ameliorates osteoarthritic inflammation in vivo and ECM macromolecules degradation in interleukin-1β-stimulated murine chondrocytes through the Nrf2/NF-κB pathway
Abstract
Introduction. Osteoarthritis (OA) is a prevailing degenerative disease in elderly population and can lead to severe joint dysfunction. Studies have revealed various pharmacological activities of diosmetin, including the anti-OA efficacy. The present study further investigated its effect on interleukin (IL)-1β-induced OA in chondrocytes.
Material and methods. Primary chondrocytes were isolated from young mice, stimulated with IL-1β (10 ng/mL), and pretreated with diosmetin (10 and 20 μM) to conduct the in vitro assays. CCK-8 assay assessed the cytotoxicity of diosmetin whereas the levels of inflammatory factors (PGE2, nitrite, TNF-α, and IL-6) in homogenized cells were evaluated by ELISA. The levels of inflammatory cytokines, content of extracellular matrix (ECM), and signaling-related proteins (Nrf2, HO-1, and NF-κB p65) were assessed by western blotting. Expression of collagen II, p65, and Nrf2 in the chondrocytes was confirmed by immunofluorescence staining. The chondrocytes treated with IL-1β and diosmetin were transfected with Nrf2 knockdown plasmid (si-Nrf2) to investigate the role of Nrf2. In vivo OA mouse model was induced by surgically destabilizing the medial meniscus (DMM). Safranin O staining was conducted to assess the OA severity in the knee-joint tissue.
Results. Diosmetin suppressed the expression of iNOS, COX-2, PGE2, nitrite, TNF-α, IL-6, MMP-13, and ADAMTS-5 induced by IL-1β in chondrocytes. The expression of p-p65, p-IκBα, and nuclear p65 was decreased whereas that of Nrf2 and HO-1 increased by diosmetin treatment in IL-1β-treated chondrocytes. Nrf2 knockdown by siRNA reversed the inhibitory effect of diosmetin on IL-1β-induced degradation of ECM proteins and inflammatory factors in cultured chondrocytes. In the DMM-induced model of OA, diosmetin alleviated cartilage degeneration and decreased the Osteoarthritis Research Society International score.
Conclusions. Diosmetin ameliorates expression of inflammation biomarkers and ECM macromolecules degradation in cultured murine chondrocytes via inactivation of NF-κB signaling by activating Nrf2/HO-1 signaling pathway.
Keywords: mouseosteoarthritischondrocytesdiosmetinECM proteinsNrf2/HO-1NF-κB
References
- Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019; 393(10182): 1745–1759.
- Glyn-Jones S, Palmer AJR, Agricola R, et al. Osteoarthritis. Lancet. 2015; 386(9991): 376–387.
- Zhang W, Ouyang H, Dass C, et al. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res. 2016; 4(1).
- Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180: 114147.
- Philp AM, Davis ET, Jones SW. Developing anti-inflammatory therapeutics for patients with osteoarthritis. Rheumatology (Oxford). 2017; 56(6): 869–881.
- Kobayashi M, Squires GR, Mousa A, et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005; 52(1): 128–135.
- Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011; 7(1): 33–42.
- Zheng Y, Zhang R, Shi W, et al. Metabolism and pharmacological activities of the natural health-benefiting compound diosmin. Food Funct. 2020; 11(10): 8472–8492.
- Fu J, Zhang Y, Yan T, et al. Comprehensive characterization of monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry. MAbs. 2019; 11(1): 106–115.
- Pakradooni R, Shukla N, Gupta K, et al. Diosmetin Induces Modulation of Igf-1 and Il-6 Levels to Alter Rictor-Akt-PKCα Cascade in Inhibition of Prostate Cancer. J Clin Med. 2021; 10(20).
- Guo G, Dong J. Diosmetin attenuates oxidative stress-induced damage to lens epithelial cells via the mitogen-activated protein kinase (MAPK) pathway. Bioengineered. 2022; 13(4): 11072–11081.
- Wang SY, Sun ZL, Liu T, et al. Flavonoids from Sophora moorcroftiana and their synergistic antibacterial effects on MRSA. Phytother Res. 2014; 28(7): 1071–1076.
- Si Q, Shi Y, Huang D, et al. Diosmetin alleviates hypoxia‑induced myocardial apoptosis by inducing autophagy through AMPK activation. Mol Med Rep. 2020; 22(2): 1335–1341.
- Xie B, Pan D, Liu H, et al. Diosmetin protects against obesity and metabolic dysfunctions through activation of adipose estrogen receptors in mice. Mol Nutr Food Res. 2021; 65(17): e2100070.
- Juárez-Reyes K, Brindis F, Medina-Campos ON, et al. Hypoglycemic, antihyperglycemic, and antioxidant effects of the edible plant Anoda cristata. J Ethnopharmacol. 2015; 161: 36–45.
- Gong X, Xiong Li, Bi C, et al. Diosmetin ameliorate type 2 diabetic mellitus by up-regulating Corynebacterium glutamicum to regulate IRS/PI3K/AKT-mediated glucose metabolism disorder in KK-Ay mice. Phytomedicine. 2021; 87: 153582.
- Shi M, Wang J, Bi F, et al. Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/ARE signaling pathway activation and NLRP3 inflammasome inhibition. Environ Toxicol. 2022; 37(6): 1529–1542.
- Li HL, Wei YY, Li XH, et al. Diosmetin has therapeutic efficacy in colitis regulating gut microbiota, inflammation, and oxidative stress via the circ-Sirt1/Sirt1 axis. Acta Pharmacol Sin. 2022; 43(4): 919–932.
- Chen Y, Wang Y, Liu M, et al. Diosmetin exhibits anti-proliferative and anti-inflammatory effects on TNF-α-stimulated human rheumatoid arthritis fibroblast-like synoviocytes through regulating the Akt and NF-κB signaling pathways. Phytother Res. 2020; 34(6): 1310–1319.
- Hu S, Huang Y, Chen Y, et al. Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats. Ann Transl Med. 2020; 8(20): 1312.
- Hsu YL, Kuo PL. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway. J Bone Miner Res. 2008; 23(6): 949–960.
- Shao S, Fu F, Wang Z, et al. Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice. J Cell Physiol. 2019; 234(8): 12701–12713.
- Sharma S, Porwal K, Kulkarni C, et al. Diosmin, a citrus fruit-derived phlebotonic bioflavonoid protects rats from chronic kidney disease-induced loss of bone mass and strength without deteriorating the renal function. Food Funct. 2022; 13(4): 2184–2199.
- Ding H, Ding H, Mu P, et al. Diosmetin inhibits subchondral bone loss and indirectly protects cartilage in a surgically-induced osteoarthritis mouse model. Chem Biol Interact. 2023; 370: 110311.
- Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage. 2007; 15(9): 1061–1069.
- Obeidat AM, Kim SY, Burt KG, et al. A standardized approach to evaluation and reporting of synovial histopathology in two surgically induced murine models of osteoarthritis. Osteoarthritis Cartilage. 2024 [Epub ahead of print].
- Glasson SS, Chambers MG, Van Den Berg WB, et al. The OARSI histopathology initiative — recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010; 18 Suppl 3: S17–S23.
- Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford). 2005; 44(1): 7–16.
- Daheshia M, Yao JQ. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol. 2008; 35(12): 2306–2312.
- Lee DH, Park JK, Choi J, et al. Anti-inflammatory effects of natural flavonoid diosmetin in IL-4 and LPS-induced macrophage activation and atopic dermatitis model. Int Immunopharmacol. 2020; 89(Pt A): 107046.
- Yu Ge, Wan R, Yin G, et al. Diosmetin ameliorates the severity of cerulein-induced acute pancreatitis in mice by inhibiting the activation of the nuclear factor-κB. Int J Clin Exp Pathol. 2014; 7(5): 2133–2142.
- Sun S, Yan Z, Shui X, et al. Astilbin prevents osteoarthritis development through the TLR4/MD-2 pathway. J Cell Mol Med. 2020; 24(22): 13104–13114.
- Zhang M, Zhang R, Zheng T, et al. Xanthohumol attenuated inflammation and ECM degradation by mediating HO-1/C/EBPβ pathway in osteoarthritis chondrocytes. Front Pharmacol. 2021; 12: 680585.
- Cook AE, Cook JL, Stoker AM. Metabolic responses of meniscus to IL-1β. J Knee Surg. 2018; 31(9): 834–840.
- Rahmati M, Nalesso G, Mobasheri A, et al. Aging and osteoarthritis: central role of the extracellular matrix. Ageing Res Rev. 2017; 40: 20–30.
- Marcu KB, Otero M, Olivotto E, et al. NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets. 2010; 11(5): 599–613.
- Choi MC, Jo J, Park J, et al. NF-κB signaling pathways in osteoarthritic cartilage destruction. Cells. 2019; 8(7).
- Wang J, Ma J, Gu JH, et al. Regulation of type II collagen, matrix metalloproteinase-13 and cell proliferation by interleukin-1β is mediated by curcumin via inhibition of NF-κB signaling in rat chondrocytes. Mol Med Rep. 2017; 16(2): 1837–1845.
- Shu C, Chen J, Lv M, et al. Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway. Bioengineered. 2022; 13(5): 13632–13642.
- Meephat S, Prasatthong P, Potue P, et al. Diosmetin ameliorates vascular dysfunction and remodeling by modulation of nrf2/ho-1 and p-JNK/p-NF-κB expression in hypertensive rats. Antioxidants (Basel). 2021; 10(9).
- Wu S, Liao X, Zhu Z, et al. Antioxidant and anti-inflammation effects of dietary phytochemicals: the Nrf2/NF-κB signalling pathway and upstream factors of Nrf2. Phytochemistry. 2022; 204: 113429.
- Miao Z, Dong M, Wang Ze, et al. Linalool inhibits the progression of osteoarthritis via the Nrf2/HO-1 signal pathway both in vitro and in vivo. Int Immunopharmacol. 2022; 113(Pt A): 109338.
- Li W, Tao C, Mao M, et al. The Nrf2/HMGB1/NF-κB axis modulates chondrocyte apoptosis and extracellular matrix degradation in osteoarthritis. Acta Biochim Biophys Sin (Shanghai). 2023; 55(5): 818–830.
